{"gene":"GRPR","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":2011,"finding":"MOR1D (a μ-opioid receptor isoform) heterodimerizes with GRPR in the spinal cord, and morphine triggers internalization of both GRPR and MOR1D together, whereas GRP specifically triggers only GRPR internalization. This MOR1D-GRPR heterodimer mediates opioid-induced itch via unidirectional cross-activation of GRPR signaling; blocking MOR1D-GRPR association attenuates morphine-induced scratching but not analgesia. Downstream effectors PLCβ3 and IP3R3 are required for this GRPR-mediated itch pathway.","method":"Co-immunoprecipitation (heterodimer identification), internalization assays, pharmacological and molecular inhibition (PLCβ3, IP3R3 knockdown), behavioral assays in mice","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP for heterodimer, multiple orthogonal methods (genetic knockdown, pharmacology, internalization assays, behavior), replicated across multiple approaches in one rigorous study","pmids":["22000021"],"is_preprint":false},{"year":2014,"finding":"5-HT1A receptor and GRPR form receptor heteromeric complexes in the spinal cord. Coactivation of 5-HT1A and GRPR greatly potentiates subthreshold GRP-induced Ca2+ transients and action potential firing of GRPR+ neurons, providing a mechanism by which the descending serotonergic system facilitates itch transmission via GRP-GRPR signaling.","method":"Immunostaining, biochemical co-immunoprecipitation, biophysical studies, electrophysiology (calcium imaging, action potential recording), pharmacological and behavioral assays","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal biochemical interaction + multiple orthogonal methods (Ca2+ imaging, electrophysiology, behavior, pharmacology) in one study","pmids":["25453842"],"is_preprint":false},{"year":2014,"finding":"GRPR-expressing spinal neurons are excitatory interneurons that receive direct and indirect synaptic inputs from C and Aδ fibers and form contacts with NK1R-expressing projection neurons. Noxious stimuli and cooling inhibit GRPR neuron activity via GABAergic signaling, whereas capsaicin enhances both excitatory and inhibitory synaptic transmission onto GRPR neurons.","method":"Electrophysiology (patch-clamp recording of synaptic inputs), immunohistochemistry, pharmacological inhibition (GABAergic blockade), behavioral assays","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct electrophysiological recording from identified GRPR neurons with pharmacological dissection, multiple orthogonal methods","pmids":["31676846"],"is_preprint":false},{"year":2014,"finding":"NMBR and GRPR mutually compensate for each other in histaminergic itch: mice lacking both NMBR and GRPR (DKO) show significant deficits in histaminergic itch, while GRPR alone is required for chloroquine-evoked (nonhistaminergic) itch. GRP can signal through both GRPR and NMBR (albeit weakly to NMBR), whereas NMB signals exclusively through NMBR. GRPR+ neurons act downstream of NMBR+ neurons to integrate histaminergic itch information.","method":"Knockout mice (Nmbr-/-, Grpr-/-, double KO), intradermal pruritogen injection behavioral assays, pharmacological analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with single and double KO mice, multiple pruritogen behavioral paradigms, replicated in multiple genotypes","pmids":["25209280"],"is_preprint":false},{"year":2014,"finding":"GRPR signals through the PI3Kγ/Akt pathway for itch transmission. GRP directly activates small-size capsaicin-sensitive DRG neurons causing calcium flux and ~20 mV membrane depolarization. GRPR activation induces Akt phosphorylation in ex vivo spinal cord and in GRPR-transfected HEK293 cells. PI3Kγ inhibition reduces GRP-induced scratching and reverses dry skin itch.","method":"Electrophysiology (calcium imaging, membrane potential recording), ex vivo spinal cord Akt phosphorylation assay, GRPR-transfected HEK293 cells, intrathecal injections, pharmacological inhibition, behavioral assays","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (electrophysiology, biochemistry in transfected cells, ex vivo tissue, pharmacology, behavior) in one study","pmids":["26658875"],"is_preprint":false},{"year":2014,"finding":"Pharmacological and genetic blockade of GRP-GRPR signaling does not significantly affect intrathecal BNP-induced scratching behavior, demonstrating that BNP-NPRA signaling is not upstream of the GRP-GRPR pathway in itch transmission.","method":"Pharmacological blockade, genetic knockout of Grpr, intrathecal BNP injection, scratching behavioral assay","journal":"Molecular pain","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic and pharmacological approaches in a single lab, but negative/epistasis result only","pmids":["24438367"],"is_preprint":false},{"year":2011,"finding":"GRPR mediates GRP-induced neutrophil chemotaxis in vivo. In vitro, GRP-induced neutrophil migration is dependent on PLC-β2, PI3K, ERK, and p38 signaling, and is independent of Gαi protein.","method":"In vivo peritoneal neutrophil recruitment assay (i.p. GRP injection, macrophage depletion, TNF neutralization), in vitro chemotaxis assay with pathway inhibitors (PLC-β2, PI3K, ERK, p38), GRPR antagonist RC-3095 blockade","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal in vitro and in vivo methods with pharmacological dissection of signaling pathway, single lab","pmids":["22203955"],"is_preprint":false},{"year":2016,"finding":"GRPr agonist bombesin (BBN) promotes epithelial-to-mesenchymal transition (EMT) in prostate cancer cells, upregulating EMT markers (TWIST, SNAIL, SLUG) and downregulating epithelial markers (E-cadherin, β-catenin). BBN increased tumor cell proliferation, migration in vitro, and tumor growth and invasion in vivo. GRPr blockade reversed these effects.","method":"Stable transfection of GRPr into Ace-1 canine prostate cancer cells, cell proliferation assay, migration assay, bioluminescence tumor growth imaging, quantitative RT-PCR for EMT markers, in vivo subcutaneous and intratibial tumor models","journal":"The Prostate","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal in vitro and in vivo methods with agonist/antagonist validation, single lab","pmids":["26939805"],"is_preprint":false},{"year":2004,"finding":"Key amino acids in GRPR responsible for high-affinity GRP binding were identified by mutagenesis: K101, Q121, A198, P199, S293, R288, T297 are particularly important for GRP selectivity. Combinations of mutations produced greater decreases in GRP affinity than single mutations. Reverse mutations in BRS-3 (making GRP gain-of-affinity mutants) confirmed these results. Modeling showed these residues have side chains oriented inward within 6Å of the binding pocket.","method":"Site-directed mutagenesis of GRPR (14 single mutants + combination mutants), radioligand binding assays, reverse mutations in BRS-3, molecular modeling","journal":"Biochemical pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic active-site mutagenesis with reciprocal validation in BRS-3, multiple mutants tested with binding assays","pmids":["15670577"],"is_preprint":false},{"year":2006,"finding":"GRP-R protein localizes predominantly to the plasma membrane in human tumor cells; after bombesin exposure, GRP-R immunostaining translocates (receptor internalization), confirming agonist-induced internalization. Receptor is detected at Mr 50,000–70,000 on Western blot and at cell surface in transfected cells.","method":"Western blot of receptor-expressing membrane fractions, immunostaining of transfected cells, receptor translocation assay after bombesin exposure, antibody preadsorbtion controls","journal":"Virchows Archiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with functional validation (agonist-induced translocation), single lab","pmids":["16967266"],"is_preprint":false},{"year":2012,"finding":"GRPR knockout mice display impaired cued fear extinction (slower extinction than wildtype), accompanied by increased c-Fos activity in the basolateral amygdala and decreased c-Fos activity in the prefrontal cortex during extinction, identifying GRPR as a regulator of amygdala-prefrontal circuit balance during fear extinction.","method":"GRPR knockout mice, cued and contextual fear conditioning/extinction behavioral paradigm, c-Fos immunostaining as indirect neuronal activity marker","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined behavioral phenotype and circuit-level activity readout, single lab","pmids":["22312434"],"is_preprint":false},{"year":2000,"finding":"GRP-R knockout male mice exhibit increased non-aggressive social responses and altered conspecific odor preference (preferring other males' odor over their own, opposite to wildtype), indicating GRPR regulates social investigatory behavior and chemosensory cognition in mice.","method":"GRP-R knockout mice, social interaction test (resident-intruder), social investigation test toward anesthetized conspecific, olfactory preference test, diazepam control","journal":"Brain research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with specific behavioral phenotype, multiple behavioral paradigms, single lab","pmids":["10869497"],"is_preprint":false},{"year":2019,"finding":"Spinal GRPR+ neurons receive inhibitory synaptic inputs from local galanin+ GABAergic neurons and local nNOS-expressing neurons, and also receive strong inhibitory inputs from the rostral ventromedial medulla (long-range). These inhibitory circuits gate GRPR+ neuron-dependent itch signaling.","method":"Viral tracing (circuit mapping), electrophysiology (patch-clamp), immunohistochemistry, Grpr-eGFP reporter mice","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — viral circuit tracing combined with electrophysiology and genetics in a single rigorous study identifying specific inhibitory partners","pmids":["31806757"],"is_preprint":false},{"year":2023,"finding":"GRPR interacts with Toll-like receptor 4 to activate STAT1, which binds the promoters of MLKL and CCL2 to induce tubular epithelial cell necroptosis, necroinflammation, and macrophage recruitment in acute kidney injury. STAT1 also induces GRP synthesis, creating a GRP/GRPR/STAT1 positive feedback loop. Histone deacetylase 8 may drive GRPR transcriptional activation.","method":"Co-immunoprecipitation (GRPR-TLR4 interaction), STAT1 ChIP (promoter binding), Grpr knockout mice, tubular-specific Grpr conditional knockout (GRPRFlox/Flox/KspCre), STAT1 overexpression rescue, GRPR antagonist RH-1402 treatment, cisplatin and ischemia AKI models","journal":"Molecular therapy","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP interaction, ChIP, multiple genetic models (global KO, conditional KO, rescue), two disease models, single lab","pmids":["37415332"],"is_preprint":false},{"year":2023,"finding":"GRP/GRPR signaling in macrophages/neutrophils promotes alcohol-associated liver injury via two parallel mechanisms: IRF1-mediated Caspase-1 inflammasome activation and NOX2-dependent reactive oxygen species production. Histone H3 lysine 27 acetylation induced by alcohol promotes GRP expression, and GRP then binds GRPR to activate these pathways.","method":"Grpr-/- mice, Grprflox/floxLysMCre (myeloid-specific conditional KO) mice, GRPR overexpression, GRPR antagonist RH-1402, chromatin/histone modification analysis, inflammatory cytokine/chemokine measurement, serum biomarkers","journal":"Hepatology","confidence":"High","confidence_rationale":"Tier 2 / Strong — global KO, myeloid-specific conditional KO, gain-of-function, and pharmacological inhibition with multiple molecular readouts, single lab","pmids":["37409771"],"is_preprint":false},{"year":2023,"finding":"GRP/GRPR signaling promotes hyperuricemia-induced renal inflammation and fibrosis by activating NF-κB, which suppresses ABCG2/PDZK1 and increases TGF-β/Smad3 levels. GRPR conditional knockout in renal tubular epithelial cells (GRPRFlox/Flox/KspCre) protected mice from hyperuricemic nephropathy.","method":"Renal tubular epithelial cell-specific conditional KO (GRPRFlox/Flox/KspCre), global GRPR KO, RNA-seq, GRPR overexpression in HK2 cells, NF-κB inhibitor rescue, GRPR antagonist RH-1402, ELISA, immunohistochemistry","journal":"Biochemical pharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-specific conditional KO with rescue experiment, RNA-seq pathway analysis, multiple genetic and pharmacological tools, single lab","pmids":["38084678"],"is_preprint":false},{"year":2020,"finding":"GRPR-expressing spinal neurons are identified as vertical cells (glutamatergic interneurons concentrated in lamina I and outer lamina II), accounting for ~15% of excitatory neurons in the superficial dorsal horn. Their axons target GRPR+ neurons themselves, lamina I NK1R projection neurons, lateral spinal nucleus, and lateral lamina V. Most GRPR cells receive monosynaptic input from Trpv1-expressing nociceptive afferents and respond to both noxious and pruritic stimuli. Chemogenetic activation produces both pain- and itch-related behaviors.","method":"GRPR-CreERT2 mouse line (conditional genetic targeting), viral tracing, electrophysiology, immunohistochemistry, RNAscope in situ hybridization, chemogenetics (DREADDs), behavioral assays","journal":"Pain","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic targeting with CreERT2, viral circuit tracing, electrophysiology, chemogenetics, and behavior in a single comprehensive study","pmids":["35543635"],"is_preprint":false},{"year":2023,"finding":"Spinal microglia NLRP3/caspase-1/IL-1β axis promotes activation of GRPR+ neurons via IL-1R1, which is expressed on GRPR+ neurons. IL-1β+ microglia localize in close proximity to GRPR+ neurons, and intrathecal IL-1β enhances GRPR+ neuron activation, while IL-1R1 antagonist attenuates chronic itch.","method":"Grpr-eGFP and Grpr KO mice, immunohistochemistry, RNAscope ISH, pharmacological blockade (NLRP3, caspase-1, IL-1R1 antagonist), intrathecal IL-1β injection, western blot, behavioral assays, RNA sequencing","journal":"Allergy","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic reporter/KO mice, direct proximity mapping of microglia-GRPR+ neuron interaction, pharmacological and genetic dissection, multiple models","pmids":["36876522"],"is_preprint":false},{"year":2020,"finding":"GRPR (and NPRA) downstream ERK1/2 phosphorylation is the most significantly upregulated signaling cascade in spinal cord during chronic itch. Phosphorylated ERK is detected in GRPR+ interneurons. Genetic blockade of GRPR significantly attenuates spinal ERK phosphorylation. In HEK293T cells transfected with GRPR, GRP activates ERK as the most prominent intracellular signaling molecule.","method":"RNA sequencing (spinal cord), western blot (pERK), MAPK/ERK kinase inhibitors, Grpr KO mice, GRPR-transfected HEK293T cells + GRP stimulation, RNAscope, behavioral assays","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 2 / Strong — transfected cell signaling assays, genetic KO, RNA-seq, and western blot with multiple itch models, single lab","pmids":["33039402"],"is_preprint":false},{"year":1997,"finding":"The GRPR gene on the X chromosome was shown to escape X-inactivation, as established by molecular analysis of a patient with an X;8 translocation whose breakpoint occurred in the first intron of GRPR.","method":"Molecular analysis of X;8 translocation patient, YAC and cosmid cloning, X-inactivation analysis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct molecular mapping, single patient, single lab; escape from X-inactivation directly demonstrated","pmids":["9259269"],"is_preprint":false},{"year":2006,"finding":"177Lu-AMBA (a radiolabeled bombesin analog) binds to GRP-R with high affinity (Kd = 1.02 nmol/L) and is internalized by GRP-R-expressing PC-3 cells (76.8% internalization), with markedly lower efflux (2.9%) compared to other analogs.","method":"Radioligand binding assay (Kd, Bmax determination), internalization and efflux assays in PC-3 cells, receptor autoradiography","journal":"Journal of nuclear medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding kinetics and internalization assays with quantified parameters, single lab","pmids":["16818949"],"is_preprint":false},{"year":2012,"finding":"ERβcx (an estrogen receptor β splice variant) regulates GRPR expression in prostate cancer cells: stable overexpression of ERβcx in PC-3 cells induces GRPR mRNA expression, and GRPR immunoreactivity correlates significantly with ERβcx expression in human prostate cancer specimens.","method":"Stable transfection of ERβcx into PC-3 cells, quantitative RT-PCR, immunohistochemistry in 51 human prostate cancer specimens","journal":"Neoplasma","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct gain-of-function (stable transfection) with gene expression readout, corroborated by human tissue correlation, single lab","pmids":["22248281"],"is_preprint":false},{"year":2024,"finding":"IL-6 upregulates GRPR expression in hippocampal neurons, and GRP-GRPR activates the PI3K-AKT/mTOR-GSK-3β pathway. GRPR knockdown in HT22 cells abolished IL-6-induced PI3K-AKT/mTOR activation and GSK-3β upregulation.","method":"Maternal immune activation mouse model, GRPR knockdown in HT22 cells (with and without GRPR), IL-6 treatment, western blot for PI3K-AKT/mTOR/GSK-3β, NetworkAnalyst bioinformatics","journal":"Journal of neuroimmune pharmacology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct loss-of-function in cell line with defined pathway readout, corroborated by in vivo expression data, single lab","pmids":["38536552"],"is_preprint":false}],"current_model":"GRPR is a G protein-coupled receptor that, upon activation by GRP, signals through PLCβ/IP3R3, PI3Kγ/Akt, and ERK1/2 pathways to mediate itch transmission in spinal cord GRPR+ interneurons (excitatory vertical cells in laminae I–II); it heterodimerizes with MOR1D for opioid-induced itch and with 5-HT1A to potentiate GRP signaling, is controlled by local galanin+/nNOS+ GABAergic interneurons and long-range inhibitory inputs from the rostral ventromedial medulla, and in peripheral immune and epithelial cells activates TLR4/STAT1, NF-κB/TGF-β/Smad3, IRF1/caspase-1 inflammasome, and NOX2/ROS pathways to drive inflammation, necroptosis, and fibrosis in contexts including acute kidney injury, alcohol-associated liver injury, and hyperuricemic nephropathy."},"narrative":{"mechanistic_narrative":"GRPR is a plasma-membrane G protein-coupled receptor for gastrin-releasing peptide (GRP) that serves as a central transmitter of itch in the spinal cord and as a driver of inflammation, necroptosis, and fibrosis in peripheral epithelial and immune tissues [PMID:35543635, PMID:37415332]. In the superficial dorsal horn, GRPR marks a population of glutamatergic vertical interneurons concentrated in laminae I–II that receive monosynaptic input from TRPV1+ nociceptors, contact NK1R+ projection neurons, and respond to both pruritic and noxious stimuli [PMID:35543635, PMID:31676846]. Upon GRP binding—mediated by an inward-facing residue cluster including K101, Q121, R288, and S293 in the ligand pocket [PMID:15670577]—activated GRPR depolarizes neurons and signals through PLCβ3/IP3R3, PI3Kγ/Akt, and ERK1/2 cascades to transmit itch [PMID:22000021, PMID:26658875, PMID:33039402]. Receptor function is tuned by heteromerization: GRPR forms a complex with the μ-opioid receptor isoform MOR1D that cross-activates GRPR to produce opioid-induced itch without affecting analgesia [PMID:22000021], and with 5-HT1A to potentiate subthreshold GRP responses under descending serotonergic drive [PMID:25453842]. GRPR+ neuron output is gated by local galanin+ and nNOS+ GABAergic interneurons and by long-range inhibitory inputs from the rostral ventromedial medulla, and is amplified by microglial NLRP3/caspase-1/IL-1β signaling acting through IL-1R1 on GRPR+ neurons in chronic itch [PMID:31806757, PMID:36876522]. GRPR also partially overlaps functionally with NMBR in histaminergic itch [PMID:25209280]. In peripheral disease, GRPR physically interacts with TLR4 to activate STAT1, driving MLKL/CCL2-dependent tubular necroptosis and a GRP/GRPR/STAT1 feedforward loop in acute kidney injury [PMID:37415332], and engages IRF1/caspase-1 inflammasome and NOX2/ROS pathways in myeloid cells in alcohol-associated liver injury [PMID:37409771] and NF-κB/TGF-β/Smad3 signaling in hyperuricemic nephropathy [PMID:38084678]. Beyond these roles, GRPR agonism promotes EMT and tumor growth in prostate cancer cells [PMID:26939805], and GRPR knockout mice show deficits in fear extinction and altered social investigatory behavior [PMID:22312434, PMID:10869497].","teleology":[{"year":2000,"claim":"Whether GRPR has functions in the brain beyond peptide signaling was addressed by phenotyping knockout mice, revealing a role in social and chemosensory behavior.","evidence":"GRPR knockout mice in resident-intruder, social investigation, and olfactory preference tests","pmids":["10869497"],"confidence":"Medium","gaps":["Circuit and molecular mechanism linking GRPR to social behavior not defined","Brain region of action not localized"]},{"year":2004,"claim":"The structural basis of GRP recognition was unknown; systematic mutagenesis mapped the residues conferring high-affinity, selective GRP binding.","evidence":"Site-directed mutagenesis of 14 single and combination mutants with radioligand binding and reciprocal gain-of-affinity mutations in BRS-3","pmids":["15670577"],"confidence":"High","gaps":["No experimental three-dimensional structure of the GRPR-GRP complex","Residues governing G protein coupling not addressed"]},{"year":2006,"claim":"Receptor trafficking behavior was clarified by showing plasma-membrane localization and agonist-induced internalization, supporting ligand-targeted imaging strategies.","evidence":"Western blot, immunostaining, and bombesin-induced translocation in tumor cells; radioligand binding/internalization with 177Lu-AMBA in PC-3 cells","pmids":["16967266","16818949"],"confidence":"Medium","gaps":["Internalization machinery and recycling fate not characterized","Quantitative kinetics restricted to tumor cell lines"]},{"year":2011,"claim":"How opioids trigger itch was resolved by showing a MOR1D-GRPR heterodimer that cross-activates GRPR/PLCβ3/IP3R3, dissociating itch from analgesia.","evidence":"Reciprocal Co-IP, internalization assays, PLCβ3/IP3R3 knockdown, pharmacology, and behavior in mice","pmids":["22000021"],"confidence":"High","gaps":["Stoichiometry and structural interface of the heterodimer unknown","Whether the heterodimer operates outside the spinal cord not tested"]},{"year":2011,"claim":"A peripheral, non-neuronal role for GRPR was established by demonstrating it drives GRP-induced neutrophil chemotaxis through a defined kinase cascade.","evidence":"In vivo peritoneal recruitment and in vitro chemotaxis with PLC-β2/PI3K/ERK/p38 inhibitors and GRPR antagonist RC-3095","pmids":["22203955"],"confidence":"High","gaps":["G protein coupling identity left open (shown Gi-independent)","In vivo contribution to specific inflammatory diseases not yet mapped"]},{"year":2012,"claim":"GRPR's CNS role was extended to emotional learning and its transcriptional control was probed, linking it to amygdala-prefrontal circuit balance and estrogen receptor regulation.","evidence":"GRPR KO mice in fear extinction with c-Fos mapping; ERβcx overexpression in PC-3 cells with RT-PCR and human tissue correlation; X-inactivation mapping in a translocation patient","pmids":["22312434","22248281","9259269"],"confidence":"Medium","gaps":["Direct transcriptional mechanism of ERβcx on GRPR promoter not shown","Causal link between GRPR circuit changes and extinction behavior is correlative (c-Fos)"]},{"year":2014,"claim":"The spinal itch circuit was defined: GRPR+ neurons are excitatory interneurons integrating afferent input, gated by GABA, with NMBR providing partial redundancy in histaminergic itch.","evidence":"Patch-clamp of identified GRPR neurons with GABAergic blockade; single and double Nmbr/Grpr knockout mice across pruritogen paradigms","pmids":["31676846","25209280"],"confidence":"High","gaps":["Molecular basis of GRP cross-signaling to NMBR not resolved","How noxious versus pruritic inputs are discriminated by these neurons unclear"]},{"year":2014,"claim":"GRPR signal facilitation and effector pathways were defined: 5-HT1A heteromerization potentiates GRP responses, and PI3Kγ/Akt is required for itch transmission, while BNP-NPRA is not upstream.","evidence":"Co-IP/Ca2+ imaging/electrophysiology for 5-HT1A; ex vivo Akt phosphorylation, HEK293 transfection, PI3Kγ inhibition and behavior; genetic/pharmacological BNP epistasis","pmids":["25453842","26658875","24438367"],"confidence":"High","gaps":["Interface and stoichiometry of the 5-HT1A-GRPR heteromer not defined","Relative contribution of PI3Kγ/Akt versus PLC and ERK arms not quantified"]},{"year":2016,"claim":"An oncogenic function was established by showing GRPR agonism drives EMT, proliferation, and invasion in prostate cancer, reversible by GRPR blockade.","evidence":"Stable GRPr transfection of Ace-1 cells with proliferation/migration assays, EMT marker RT-PCR, and in vivo tumor models","pmids":["26939805"],"confidence":"High","gaps":["Intracellular signaling pathway coupling GRPR to EMT transcription factors not delineated","Endogenous ligand source in the tumor microenvironment unknown"]},{"year":2020,"claim":"The identity and connectivity of spinal GRPR+ neurons and their dominant signaling output were resolved, defining them as nociceptor-innervated vertical cells signaling through ERK1/2.","evidence":"GRPR-CreERT2 mice with viral tracing, electrophysiology, chemogenetics; RNA-seq and pERK western blot in itch models plus GRPR-HEK293T signaling","pmids":["35543635","33039402"],"confidence":"High","gaps":["How a single population encodes both pain and itch is unresolved","Hierarchy among PLCβ, PI3Kγ, and ERK arms in vivo not established"]},{"year":2023,"claim":"Top-down and bottom-up control of GRPR+ neurons in chronic itch was mapped, identifying inhibitory gating circuits and microglial inflammasome-driven facilitation.","evidence":"Viral tracing/electrophysiology of galanin+/nNOS+/RVM inputs; Grpr reporter and KO mice with NLRP3/caspase-1/IL-1R1 pharmacology and intrathecal IL-1β","pmids":["31806757","36876522"],"confidence":"High","gaps":["Conditions selecting disinhibition versus microglial facilitation not defined","Direct synaptic versus diffusible action of microglial IL-1β not fully separated"]},{"year":2023,"claim":"GRPR's peripheral pathogenic role was mechanistically expanded across organs, defining receptor-TLR4 coupling and distinct downstream inflammatory effectors in kidney and liver injury.","evidence":"GRPR-TLR4 Co-IP and STAT1 ChIP with global/conditional Grpr KO in AKI; myeloid-specific KO with IRF1/caspase-1 and NOX2 readouts in liver injury; tubular-specific KO with NF-κB/TGF-β/Smad3 in hyperuricemic nephropathy","pmids":["37415332","37409771","38084678"],"confidence":"High","gaps":["Whether GRPR-TLR4 forms a direct stable complex or transient assembly is unresolved","Source and regulation of local GRP ligand in each disease not fully defined"]},{"year":2024,"claim":"A cytokine-driven CNS signaling link was identified, with IL-6 upregulating GRPR to engage PI3K-AKT/mTOR-GSK-3β in hippocampal neurons.","evidence":"Maternal immune activation model with GRPR knockdown in HT22 cells, IL-6 treatment, and pathway western blots","pmids":["38536552"],"confidence":"Medium","gaps":["Mechanism of IL-6-driven GRPR transcriptional upregulation not defined","Behavioral consequence of hippocampal GRPR signaling not established"]},{"year":null,"claim":"A unified picture of how GRPR's G protein coupling and effector arm selection (PLCβ/IP3R3 vs PI3Kγ/Akt vs ERK) is biased across neuronal versus immune/epithelial contexts, and the structural basis of its heteromeric and TLR4 partnerships, remains open.","evidence":"","pmids":[],"confidence":"Low","gaps":["No experimental GRPR structure or activation-state model","Mechanism dictating context-specific effector selection unknown","Direct versus indirect nature of GRPR-TLR4 interaction unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,4,8,16]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[9,20]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,4,18]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[2,16,12,17]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[6,13,14]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[13,14,15,7]}],"complexes":[],"partners":["MOR1D","HTR1A","TLR4","NMBR"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P30550","full_name":"Gastrin-releasing peptide receptor","aliases":["GRP-preferring bombesin receptor"],"length_aa":384,"mass_kda":43.2,"function":"Receptor for gastrin-releasing peptide (GRP) (PubMed:1655761). Signals via association with G proteins that activate a phosphatidylinositol-calcium second messenger system, resulting in Akt phosphorylation. Contributes to the regulation of food intake. Contributes to the perception of prurient stimuli and transmission of itch signals in the spinal cord that promote scratching behavior, but does not play a role in the perception of pain. Contributes primarily to nonhistaminergic itch sensation. In one study, shown to act in the amygdala as part of an inhibitory network which inhibits memory specifically related to learned fear (By similarity). In another study, shown to contribute to disinhibition of glutamatergic cells in the auditory cortex via signaling on vasoactive intestinal peptide-expressing cells which leads to enhanced auditory fear memories (By similarity). Contributes to the induction of sighing through signaling in the pre-Botzinger complex, a cluster of several thousand neurons in the ventrolateral medulla responsible for inspiration during respiratory activity (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P30550/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GRPR","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GRPR","total_profiled":1310},"omim":[{"mim_id":"607563","title":"SOLUTE CARRIER FAMILY 17 (VESICULAR GLUTAMATE COTRANSPORTER), MEMBER 6; SLC17A6","url":"https://www.omim.org/entry/607563"},{"mim_id":"312750","title":"RETT SYNDROME; RTT","url":"https://www.omim.org/entry/312750"},{"mim_id":"305670","title":"GASTRIN-RELEASING PEPTIDE RECEPTOR; GRPR","url":"https://www.omim.org/entry/305670"},{"mim_id":"300170","title":"OFD1 CENTRIOLE AND CENTRIOLAR SATELLITE PROTEIN; OFD1","url":"https://www.omim.org/entry/300170"},{"mim_id":"162341","title":"NEUROMEDIN B RECEPTOR; NMBR","url":"https://www.omim.org/entry/162341"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"pancreas","ntpm":19.1}],"url":"https://www.proteinatlas.org/search/GRPR"},"hgnc":{"alias_symbol":["BB2","BB2R","BRS2"],"prev_symbol":[]},"alphafold":{"accession":"P30550","domains":[{"cath_id":"1.20.1070.10","chopping":"40-176_204-242_255-336","consensus_level":"high","plddt":92.8348,"start":40,"end":336}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P30550","model_url":"https://alphafold.ebi.ac.uk/files/AF-P30550-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P30550-F1-predicted_aligned_error_v6.png","plddt_mean":78.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GRPR","jax_strain_url":"https://www.jax.org/strain/search?query=GRPR"},"sequence":{"accession":"P30550","fasta_url":"https://rest.uniprot.org/uniprotkb/P30550.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P30550/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P30550"}},"corpus_meta":[{"pmid":"22000021","id":"PMC_22000021","title":"Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22000021","citation_count":211,"is_preprint":false},{"pmid":"16818949","id":"PMC_16818949","title":"177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.","date":"2006","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16818949","citation_count":166,"is_preprint":false},{"pmid":"20717822","id":"PMC_20717822","title":"Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours.","date":"2010","source":"European journal of nuclear medicine and molecular imaging","url":"https://pubmed.ncbi.nlm.nih.gov/20717822","citation_count":164,"is_preprint":false},{"pmid":"19360404","id":"PMC_19360404","title":"(68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging.","date":"2009","source":"European journal of nuclear medicine and molecular imaging","url":"https://pubmed.ncbi.nlm.nih.gov/19360404","citation_count":122,"is_preprint":false},{"pmid":"27609789","id":"PMC_27609789","title":"68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.","date":"2016","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27609789","citation_count":104,"is_preprint":false},{"pmid":"23507930","id":"PMC_23507930","title":"Targeting GRPR in urological cancers--from basic research to clinical application.","date":"2013","source":"Nature reviews. Urology","url":"https://pubmed.ncbi.nlm.nih.gov/23507930","citation_count":95,"is_preprint":false},{"pmid":"24464532","id":"PMC_24464532","title":"Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer.","date":"2014","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/24464532","citation_count":95,"is_preprint":false},{"pmid":"25453842","id":"PMC_25453842","title":"Descending control of itch transmission by the serotonergic system via 5-HT1A-facilitated GRP-GRPR signaling.","date":"2014","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/25453842","citation_count":95,"is_preprint":false},{"pmid":"29123014","id":"PMC_29123014","title":"PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients.","date":"2017","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29123014","citation_count":89,"is_preprint":false},{"pmid":"9259269","id":"PMC_9259269","title":"Autism and multiple exostoses associated with an X;8 translocation occurring within the GRPR gene and 3' to the SDC2 gene.","date":"1997","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9259269","citation_count":88,"is_preprint":false},{"pmid":"23763444","id":"PMC_23763444","title":"Synthesis and characterization of a high-affinity NOTA-conjugated bombesin antagonist for GRPR-targeted tumor imaging.","date":"2013","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23763444","citation_count":71,"is_preprint":false},{"pmid":"21544226","id":"PMC_21544226","title":"F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging.","date":"2011","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/21544226","citation_count":70,"is_preprint":false},{"pmid":"15872357","id":"PMC_15872357","title":"Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs.","date":"2005","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15872357","citation_count":68,"is_preprint":false},{"pmid":"22203955","id":"PMC_22203955","title":"Gastrin-releasing peptide receptor (GRPR) mediates chemotaxis in neutrophils.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22203955","citation_count":67,"is_preprint":false},{"pmid":"29464003","id":"PMC_29464003","title":"68Ga-BBN-RGD PET/CT for GRPR and Integrin αvβ3 Imaging in Patients with Breast Cancer.","date":"2018","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/29464003","citation_count":66,"is_preprint":false},{"pmid":"19910427","id":"PMC_19910427","title":"177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression.","date":"2009","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19910427","citation_count":65,"is_preprint":false},{"pmid":"26726823","id":"PMC_26726823","title":"Novel Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer.","date":"2016","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26726823","citation_count":60,"is_preprint":false},{"pmid":"24438367","id":"PMC_24438367","title":"B-type natriuretic peptide is neither itch-specific nor functions upstream of the GRP-GRPR signaling pathway.","date":"2014","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/24438367","citation_count":59,"is_preprint":false},{"pmid":"31366895","id":"PMC_31366895","title":"Comparative Study of Subcutaneous and Orthotopic Mouse Models of Prostate Cancer: Vascular Perfusion, Vasculature Density, Hypoxic Burden and BB2r-Targeting Efficacy.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31366895","citation_count":58,"is_preprint":false},{"pmid":"31017093","id":"PMC_31017093","title":"Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.","date":"2018","source":"European urology oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31017093","citation_count":58,"is_preprint":false},{"pmid":"33674398","id":"PMC_33674398","title":"PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer.","date":"2021","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33674398","citation_count":54,"is_preprint":false},{"pmid":"25209280","id":"PMC_25209280","title":"Cross-inhibition of NMBR and GRPR signaling maintains normal histaminergic itch transmission.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25209280","citation_count":50,"is_preprint":false},{"pmid":"31806757","id":"PMC_31806757","title":"Synaptic control of spinal GRPR+ neurons by local and long-range inhibitory inputs.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31806757","citation_count":47,"is_preprint":false},{"pmid":"34124036","id":"PMC_34124036","title":"Exosomes Isolated From Bone Marrow Mesenchymal Stem Cells Exert a Protective Effect on Osteoarthritis via lncRNA LYRM4-AS1-GRPR-miR-6515-5p.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34124036","citation_count":45,"is_preprint":false},{"pmid":"24727373","id":"PMC_24727373","title":"PSMA, EpCAM, VEGF and GRPR as imaging targets in locally recurrent prostate cancer after radiotherapy.","date":"2014","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24727373","citation_count":44,"is_preprint":false},{"pmid":"31540122","id":"PMC_31540122","title":"Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31540122","citation_count":42,"is_preprint":false},{"pmid":"32649787","id":"PMC_32649787","title":"Peptide-Conjugated Long-Lived Theranostic Imaging for Targeting GRPr in Cancer and Immune Cells.","date":"2020","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/32649787","citation_count":42,"is_preprint":false},{"pmid":"24508213","id":"PMC_24508213","title":"Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.","date":"2014","source":"Nuclear medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/24508213","citation_count":41,"is_preprint":false},{"pmid":"31676846","id":"PMC_31676846","title":"Pain Inhibits GRPR Neurons via GABAergic Signaling in the Spinal Cord.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31676846","citation_count":39,"is_preprint":false},{"pmid":"33789933","id":"PMC_33789933","title":"GRPr Antagonist 68Ga-SB3 PET/CT Imaging of Primary Prostate Cancer in Therapy-Naïve Patients.","date":"2021","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33789933","citation_count":39,"is_preprint":false},{"pmid":"24480266","id":"PMC_24480266","title":"A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors.","date":"2013","source":"Nuclear medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/24480266","citation_count":38,"is_preprint":false},{"pmid":"22248281","id":"PMC_22248281","title":"Immunohistochemical analysis of gastrin-releasing peptide receptor (GRPR) and possible regulation by estrogen receptor βcx in human prostate carcinoma.","date":"2012","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/22248281","citation_count":37,"is_preprint":false},{"pmid":"24312607","id":"PMC_24312607","title":"In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24312607","citation_count":37,"is_preprint":false},{"pmid":"18975117","id":"PMC_18975117","title":"In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues.","date":"2008","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/18975117","citation_count":34,"is_preprint":false},{"pmid":"34474862","id":"PMC_34474862","title":"Magnetic and GRPR-targeted reduced graphene oxide/doxorubicin nanocomposite for dual-targeted chemo-photothermal cancer therapy.","date":"2021","source":"Materials science & engineering. C, Materials for biological applications","url":"https://pubmed.ncbi.nlm.nih.gov/34474862","citation_count":33,"is_preprint":false},{"pmid":"22312434","id":"PMC_22312434","title":"Murine GRPR and stathmin control in opposite directions both cued fear extinction and neural activities of the amygdala and prefrontal cortex.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22312434","citation_count":32,"is_preprint":false},{"pmid":"37409771","id":"PMC_37409771","title":"GRP/GRPR enhances alcohol-associated liver injury through the IRF1-mediated Caspase-1 inflammasome and NOX2-dependent ROS pathway.","date":"2023","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/37409771","citation_count":31,"is_preprint":false},{"pmid":"32032577","id":"PMC_32032577","title":"Spinal GRPR and NPRA Contribute to Chronic Itch in a Murine Model of Allergic Contact Dermatitis.","date":"2020","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/32032577","citation_count":31,"is_preprint":false},{"pmid":"25797109","id":"PMC_25797109","title":"GRPR-selective PET imaging of prostate cancer using [(18)F]-lanthionine-bombesin analogs.","date":"2015","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/25797109","citation_count":31,"is_preprint":false},{"pmid":"7759104","id":"PMC_7759104","title":"A 6-Mb YAC contig in Xp22.1-p22.2 spanning the DXS69E, XE59, GLRA2, PIGA, GRPR, CALB3, and PHKA2 genes.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7759104","citation_count":31,"is_preprint":false},{"pmid":"26939805","id":"PMC_26939805","title":"Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer.","date":"2016","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/26939805","citation_count":30,"is_preprint":false},{"pmid":"19642024","id":"PMC_19642024","title":"BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells.","date":"2009","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/19642024","citation_count":30,"is_preprint":false},{"pmid":"30645633","id":"PMC_30645633","title":"Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30645633","citation_count":30,"is_preprint":false},{"pmid":"36876522","id":"PMC_36876522","title":"Microglia-neuron interactions promote chronic itch via the NLRP3-IL-1β-GRPR axis.","date":"2023","source":"Allergy","url":"https://pubmed.ncbi.nlm.nih.gov/36876522","citation_count":29,"is_preprint":false},{"pmid":"24533789","id":"PMC_24533789","title":"PESIN multimerization improves receptor avidities and in vivo tumor targeting properties to GRPR-overexpressing tumors.","date":"2014","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24533789","citation_count":29,"is_preprint":false},{"pmid":"36933382","id":"PMC_36933382","title":"Novel insight on GRP/GRPR axis in diseases.","date":"2023","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/36933382","citation_count":28,"is_preprint":false},{"pmid":"35543635","id":"PMC_35543635","title":"Grpr expression defines a population of superficial dorsal horn vertical cells that have a role in both itch and pain.","date":"2022","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/35543635","citation_count":28,"is_preprint":false},{"pmid":"26658875","id":"PMC_26658875","title":"GRPR/PI3Kγ: Partners in Central Transmission of Itch.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26658875","citation_count":28,"is_preprint":false},{"pmid":"29097932","id":"PMC_29097932","title":"High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26.","date":"2017","source":"Contrast media & molecular imaging","url":"https://pubmed.ncbi.nlm.nih.gov/29097932","citation_count":28,"is_preprint":false},{"pmid":"32630176","id":"PMC_32630176","title":"Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model.","date":"2020","source":"Pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/32630176","citation_count":28,"is_preprint":false},{"pmid":"31161459","id":"PMC_31161459","title":"Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples.","date":"2019","source":"EJNMMI research","url":"https://pubmed.ncbi.nlm.nih.gov/31161459","citation_count":28,"is_preprint":false},{"pmid":"26897133","id":"PMC_26897133","title":"Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumors.","date":"2016","source":"EJNMMI research","url":"https://pubmed.ncbi.nlm.nih.gov/26897133","citation_count":28,"is_preprint":false},{"pmid":"28500250","id":"PMC_28500250","title":"Characterization of NMB, GRP and their receptors (BRS3, NMBR and GRPR) in chickens.","date":"2017","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28500250","citation_count":27,"is_preprint":false},{"pmid":"24633452","id":"PMC_24633452","title":"A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.","date":"2014","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/24633452","citation_count":27,"is_preprint":false},{"pmid":"29137110","id":"PMC_29137110","title":"NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice.","date":"2017","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/29137110","citation_count":27,"is_preprint":false},{"pmid":"34680243","id":"PMC_34680243","title":"[99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34680243","citation_count":26,"is_preprint":false},{"pmid":"20857927","id":"PMC_20857927","title":"In vitro and in vivo characterization of novel 18F-labeled bombesin analogues for targeting GRPR-positive tumors.","date":"2010","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20857927","citation_count":26,"is_preprint":false},{"pmid":"38020178","id":"PMC_38020178","title":"GRPR-targeting radiotheranostics for breast cancer management.","date":"2023","source":"Frontiers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38020178","citation_count":25,"is_preprint":false},{"pmid":"31340483","id":"PMC_31340483","title":"Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer.","date":"2019","source":"Pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/31340483","citation_count":25,"is_preprint":false},{"pmid":"36980517","id":"PMC_36980517","title":"Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/36980517","citation_count":25,"is_preprint":false},{"pmid":"16967266","id":"PMC_16967266","title":"Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies.","date":"2006","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16967266","citation_count":25,"is_preprint":false},{"pmid":"10869497","id":"PMC_10869497","title":"Male mice lacking the gastrin-releasing peptide receptor (GRP-R) display elevated preference for conspecific odors and increased social investigatory behaviors.","date":"2000","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/10869497","citation_count":25,"is_preprint":false},{"pmid":"37415332","id":"PMC_37415332","title":"Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosis.","date":"2023","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37415332","citation_count":24,"is_preprint":false},{"pmid":"15670577","id":"PMC_15670577","title":"Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).","date":"2004","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15670577","citation_count":24,"is_preprint":false},{"pmid":"38536552","id":"PMC_38536552","title":"IL-6 Enhances the Activation of PI3K-AKT/mTOR-GSK-3β by Upregulating GRPR in Hippocampal Neurons of Autistic Mice.","date":"2024","source":"Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38536552","citation_count":24,"is_preprint":false},{"pmid":"36834815","id":"PMC_36834815","title":"Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide-Drug Conjugates.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36834815","citation_count":23,"is_preprint":false},{"pmid":"9479493","id":"PMC_9479493","title":"Human FIGF: cloning, gene structure, and mapping to chromosome Xp22.1 between the PIGA and the GRPR genes.","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9479493","citation_count":23,"is_preprint":false},{"pmid":"26577829","id":"PMC_26577829","title":"GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26577829","citation_count":22,"is_preprint":false},{"pmid":"25474596","id":"PMC_25474596","title":"Evaluation of three different families of bombesin receptor radioantagonists for targeted imaging and therapy of gastrin releasing peptide receptor (GRP-R) positive tumors.","date":"2014","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25474596","citation_count":22,"is_preprint":false},{"pmid":"31745219","id":"PMC_31745219","title":"Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31745219","citation_count":22,"is_preprint":false},{"pmid":"27399868","id":"PMC_27399868","title":"Preclinical Study on GRPR-Targeted (68)Ga-Probes for PET Imaging of Prostate Cancer.","date":"2016","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27399868","citation_count":21,"is_preprint":false},{"pmid":"8406441","id":"PMC_8406441","title":"Comparative mapping of the Grpr locus on the X chromosomes of man and mouse.","date":"1993","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8406441","citation_count":20,"is_preprint":false},{"pmid":"37934025","id":"PMC_37934025","title":"Preclinical Comparison of the 64Cu- and 68Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [68Ga]Ga-AMTG PET/CT.","date":"2023","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37934025","citation_count":19,"is_preprint":false},{"pmid":"33595022","id":"PMC_33595022","title":"GRPr-mediated photothermal and thermodynamic dual-therapy for prostate cancer with synergistic anti-apoptosis mechanism.","date":"2021","source":"Nanoscale","url":"https://pubmed.ncbi.nlm.nih.gov/33595022","citation_count":19,"is_preprint":false},{"pmid":"33801382","id":"PMC_33801382","title":"In Vivo Biodistribution and Efficacy Evaluation of NeoB, a Radiotracer Targeted to GRPR, in Mice Bearing Gastrointestinal Stromal Tumor.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33801382","citation_count":19,"is_preprint":false},{"pmid":"23590837","id":"PMC_23590837","title":"Preclinical evaluation of a novel ¹¹¹In-labeled bombesin homodimer for improved imaging of GRPR-positive prostate cancer.","date":"2013","source":"Molecular pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/23590837","citation_count":19,"is_preprint":false},{"pmid":"38442298","id":"PMC_38442298","title":"Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer.","date":"2024","source":"Annals of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38442298","citation_count":18,"is_preprint":false},{"pmid":"38169486","id":"PMC_38169486","title":"Lower-grade gliomas surgery guided by GRPR-targeting PET/NIR dual-modality image probe: a prospective and single-arm clinical trial.","date":"2024","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/38169486","citation_count":18,"is_preprint":false},{"pmid":"33039402","id":"PMC_33039402","title":"GRPR/Extracellular Signal-Regulated Kinase and NPRA/Extracellular Signal-Regulated Kinase Signaling Pathways Play a Critical Role in Spinal Transmission of Chronic Itch.","date":"2020","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/33039402","citation_count":18,"is_preprint":false},{"pmid":"24649138","id":"PMC_24649138","title":"Influence of GRPR and BDNF/TrkB signaling on the viability of breast and gynecologic cancer cells.","date":"2012","source":"Molecular and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24649138","citation_count":18,"is_preprint":false},{"pmid":"38376806","id":"PMC_38376806","title":"Synthesis, preclinical, and initial clinical evaluation of integrin αVβ3 and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [68Ga]Ga-RGD-RM26-03.","date":"2024","source":"European journal of nuclear medicine and molecular imaging","url":"https://pubmed.ncbi.nlm.nih.gov/38376806","citation_count":18,"is_preprint":false},{"pmid":"33534560","id":"PMC_33534560","title":"Development of Heterobivalent Theranostic Probes Having High Affinity/Selectivity for the GRPR/PSMA.","date":"2021","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33534560","citation_count":18,"is_preprint":false},{"pmid":"35744904","id":"PMC_35744904","title":"68Ga-Labeled [Leu13ψThz14]Bombesin(7-14) Derivatives: Promising GRPR-Targeting PET Tracers with Low Pancreas Uptake.","date":"2022","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35744904","citation_count":18,"is_preprint":false},{"pmid":"18452185","id":"PMC_18452185","title":"Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorder.","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18452185","citation_count":17,"is_preprint":false},{"pmid":"22833158","id":"PMC_22833158","title":"Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer.","date":"2012","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/22833158","citation_count":17,"is_preprint":false},{"pmid":"28294319","id":"PMC_28294319","title":"GRPR antagonist protects from drug-induced liver injury by impairing neutrophil chemotaxis and motility.","date":"2017","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28294319","citation_count":16,"is_preprint":false},{"pmid":"33664646","id":"PMC_33664646","title":"100 Hz Electroacupuncture Alleviated Chronic Itch and GRPR Expression Through Activation of Kappa Opioid Receptors in Spinal Dorsal Horn.","date":"2021","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33664646","citation_count":16,"is_preprint":false},{"pmid":"31270559","id":"PMC_31270559","title":"68Ga-NOTA-Aca-BBN(7-14) PET imaging of GRPR in children with optic pathway glioma.","date":"2019","source":"European journal of nuclear medicine and molecular imaging","url":"https://pubmed.ncbi.nlm.nih.gov/31270559","citation_count":16,"is_preprint":false},{"pmid":"25426011","id":"PMC_25426011","title":"The Gastrin-Releasing Peptide Receptor (GRPR) in the Spinal Cord as a Novel Pharmacological Target.","date":"2014","source":"Current neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25426011","citation_count":16,"is_preprint":false},{"pmid":"32618007","id":"PMC_32618007","title":"Functional Hybrid Molecules for the Visualization of Cancer: PESIN-Homodimers Combined with Multimodal Molecular Imaging Probes for Positron Emission Tomography and Optical Imaging: Suited for Tracking of GRPR-Positive Malignant Tissue*.","date":"2020","source":"Chemistry (Weinheim an der Bergstrasse, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/32618007","citation_count":16,"is_preprint":false},{"pmid":"38279185","id":"PMC_38279185","title":"Advances of radiolabeled GRPR ligands for PET/CT imaging of cancers.","date":"2024","source":"Cancer imaging : the official publication of the International Cancer Imaging Society","url":"https://pubmed.ncbi.nlm.nih.gov/38279185","citation_count":15,"is_preprint":false},{"pmid":"33140758","id":"PMC_33140758","title":"GRPR-targeted SPECT imaging using a novel bombesin-based peptide for colorectal cancer detection.","date":"2020","source":"Biomaterials science","url":"https://pubmed.ncbi.nlm.nih.gov/33140758","citation_count":15,"is_preprint":false},{"pmid":"38084678","id":"PMC_38084678","title":"GRP/GRPR signaling pathway aggravates hyperuricemia-induced renal inflammation and fibrosis via ABCG2-dependent mechanisms.","date":"2023","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38084678","citation_count":14,"is_preprint":false},{"pmid":"32886303","id":"PMC_32886303","title":"Development and Preclinical Evaluation of 99mTc- and 186Re-Labeled NOTA and NODAGA Bioconjugates Demonstrating Matched Pair Targeting of GRPR-Expressing Tumors.","date":"2020","source":"Molecular imaging and biology","url":"https://pubmed.ncbi.nlm.nih.gov/32886303","citation_count":14,"is_preprint":false},{"pmid":"33573232","id":"PMC_33573232","title":"Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer.","date":"2021","source":"Pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/33573232","citation_count":14,"is_preprint":false},{"pmid":"28636973","id":"PMC_28636973","title":"Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors.","date":"2017","source":"Nuclear medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/28636973","citation_count":14,"is_preprint":false},{"pmid":"35563666","id":"PMC_35563666","title":"Dose Rate Effects on the Selective Radiosensitization of Prostate Cells by GRPR-Targeted Gold Nanoparticles.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35563666","citation_count":14,"is_preprint":false},{"pmid":"29154145","id":"PMC_29154145","title":"Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [64Cu]-DOTHA2-PEG-RM26.","date":"2017","source":"Nuclear medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/29154145","citation_count":14,"is_preprint":false},{"pmid":"33574368","id":"PMC_33574368","title":"66Ga-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [66Ga]Ga-NOTA-PEG2-RM26.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33574368","citation_count":13,"is_preprint":false},{"pmid":"37516088","id":"PMC_37516088","title":"Antipruritic effects of geraniol on acute and chronic itch via modulating spinal GABA/GRPR signaling.","date":"2023","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37516088","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":62444,"output_tokens":6211,"usd":0.140248,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15125,"output_tokens":4996,"usd":0.100263,"stage2_stop_reason":"end_turn"},"total_usd":0.240511,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"MOR1D (a μ-opioid receptor isoform) heterodimerizes with GRPR in the spinal cord, and morphine triggers internalization of both GRPR and MOR1D together, whereas GRP specifically triggers only GRPR internalization. This MOR1D-GRPR heterodimer mediates opioid-induced itch via unidirectional cross-activation of GRPR signaling; blocking MOR1D-GRPR association attenuates morphine-induced scratching but not analgesia. Downstream effectors PLCβ3 and IP3R3 are required for this GRPR-mediated itch pathway.\",\n      \"method\": \"Co-immunoprecipitation (heterodimer identification), internalization assays, pharmacological and molecular inhibition (PLCβ3, IP3R3 knockdown), behavioral assays in mice\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP for heterodimer, multiple orthogonal methods (genetic knockdown, pharmacology, internalization assays, behavior), replicated across multiple approaches in one rigorous study\",\n      \"pmids\": [\"22000021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"5-HT1A receptor and GRPR form receptor heteromeric complexes in the spinal cord. Coactivation of 5-HT1A and GRPR greatly potentiates subthreshold GRP-induced Ca2+ transients and action potential firing of GRPR+ neurons, providing a mechanism by which the descending serotonergic system facilitates itch transmission via GRP-GRPR signaling.\",\n      \"method\": \"Immunostaining, biochemical co-immunoprecipitation, biophysical studies, electrophysiology (calcium imaging, action potential recording), pharmacological and behavioral assays\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal biochemical interaction + multiple orthogonal methods (Ca2+ imaging, electrophysiology, behavior, pharmacology) in one study\",\n      \"pmids\": [\"25453842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GRPR-expressing spinal neurons are excitatory interneurons that receive direct and indirect synaptic inputs from C and Aδ fibers and form contacts with NK1R-expressing projection neurons. Noxious stimuli and cooling inhibit GRPR neuron activity via GABAergic signaling, whereas capsaicin enhances both excitatory and inhibitory synaptic transmission onto GRPR neurons.\",\n      \"method\": \"Electrophysiology (patch-clamp recording of synaptic inputs), immunohistochemistry, pharmacological inhibition (GABAergic blockade), behavioral assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct electrophysiological recording from identified GRPR neurons with pharmacological dissection, multiple orthogonal methods\",\n      \"pmids\": [\"31676846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NMBR and GRPR mutually compensate for each other in histaminergic itch: mice lacking both NMBR and GRPR (DKO) show significant deficits in histaminergic itch, while GRPR alone is required for chloroquine-evoked (nonhistaminergic) itch. GRP can signal through both GRPR and NMBR (albeit weakly to NMBR), whereas NMB signals exclusively through NMBR. GRPR+ neurons act downstream of NMBR+ neurons to integrate histaminergic itch information.\",\n      \"method\": \"Knockout mice (Nmbr-/-, Grpr-/-, double KO), intradermal pruritogen injection behavioral assays, pharmacological analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with single and double KO mice, multiple pruritogen behavioral paradigms, replicated in multiple genotypes\",\n      \"pmids\": [\"25209280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GRPR signals through the PI3Kγ/Akt pathway for itch transmission. GRP directly activates small-size capsaicin-sensitive DRG neurons causing calcium flux and ~20 mV membrane depolarization. GRPR activation induces Akt phosphorylation in ex vivo spinal cord and in GRPR-transfected HEK293 cells. PI3Kγ inhibition reduces GRP-induced scratching and reverses dry skin itch.\",\n      \"method\": \"Electrophysiology (calcium imaging, membrane potential recording), ex vivo spinal cord Akt phosphorylation assay, GRPR-transfected HEK293 cells, intrathecal injections, pharmacological inhibition, behavioral assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (electrophysiology, biochemistry in transfected cells, ex vivo tissue, pharmacology, behavior) in one study\",\n      \"pmids\": [\"26658875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Pharmacological and genetic blockade of GRP-GRPR signaling does not significantly affect intrathecal BNP-induced scratching behavior, demonstrating that BNP-NPRA signaling is not upstream of the GRP-GRPR pathway in itch transmission.\",\n      \"method\": \"Pharmacological blockade, genetic knockout of Grpr, intrathecal BNP injection, scratching behavioral assay\",\n      \"journal\": \"Molecular pain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic and pharmacological approaches in a single lab, but negative/epistasis result only\",\n      \"pmids\": [\"24438367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GRPR mediates GRP-induced neutrophil chemotaxis in vivo. In vitro, GRP-induced neutrophil migration is dependent on PLC-β2, PI3K, ERK, and p38 signaling, and is independent of Gαi protein.\",\n      \"method\": \"In vivo peritoneal neutrophil recruitment assay (i.p. GRP injection, macrophage depletion, TNF neutralization), in vitro chemotaxis assay with pathway inhibitors (PLC-β2, PI3K, ERK, p38), GRPR antagonist RC-3095 blockade\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal in vitro and in vivo methods with pharmacological dissection of signaling pathway, single lab\",\n      \"pmids\": [\"22203955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GRPr agonist bombesin (BBN) promotes epithelial-to-mesenchymal transition (EMT) in prostate cancer cells, upregulating EMT markers (TWIST, SNAIL, SLUG) and downregulating epithelial markers (E-cadherin, β-catenin). BBN increased tumor cell proliferation, migration in vitro, and tumor growth and invasion in vivo. GRPr blockade reversed these effects.\",\n      \"method\": \"Stable transfection of GRPr into Ace-1 canine prostate cancer cells, cell proliferation assay, migration assay, bioluminescence tumor growth imaging, quantitative RT-PCR for EMT markers, in vivo subcutaneous and intratibial tumor models\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal in vitro and in vivo methods with agonist/antagonist validation, single lab\",\n      \"pmids\": [\"26939805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Key amino acids in GRPR responsible for high-affinity GRP binding were identified by mutagenesis: K101, Q121, A198, P199, S293, R288, T297 are particularly important for GRP selectivity. Combinations of mutations produced greater decreases in GRP affinity than single mutations. Reverse mutations in BRS-3 (making GRP gain-of-affinity mutants) confirmed these results. Modeling showed these residues have side chains oriented inward within 6Å of the binding pocket.\",\n      \"method\": \"Site-directed mutagenesis of GRPR (14 single mutants + combination mutants), radioligand binding assays, reverse mutations in BRS-3, molecular modeling\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic active-site mutagenesis with reciprocal validation in BRS-3, multiple mutants tested with binding assays\",\n      \"pmids\": [\"15670577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GRP-R protein localizes predominantly to the plasma membrane in human tumor cells; after bombesin exposure, GRP-R immunostaining translocates (receptor internalization), confirming agonist-induced internalization. Receptor is detected at Mr 50,000–70,000 on Western blot and at cell surface in transfected cells.\",\n      \"method\": \"Western blot of receptor-expressing membrane fractions, immunostaining of transfected cells, receptor translocation assay after bombesin exposure, antibody preadsorbtion controls\",\n      \"journal\": \"Virchows Archiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with functional validation (agonist-induced translocation), single lab\",\n      \"pmids\": [\"16967266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GRPR knockout mice display impaired cued fear extinction (slower extinction than wildtype), accompanied by increased c-Fos activity in the basolateral amygdala and decreased c-Fos activity in the prefrontal cortex during extinction, identifying GRPR as a regulator of amygdala-prefrontal circuit balance during fear extinction.\",\n      \"method\": \"GRPR knockout mice, cued and contextual fear conditioning/extinction behavioral paradigm, c-Fos immunostaining as indirect neuronal activity marker\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined behavioral phenotype and circuit-level activity readout, single lab\",\n      \"pmids\": [\"22312434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"GRP-R knockout male mice exhibit increased non-aggressive social responses and altered conspecific odor preference (preferring other males' odor over their own, opposite to wildtype), indicating GRPR regulates social investigatory behavior and chemosensory cognition in mice.\",\n      \"method\": \"GRP-R knockout mice, social interaction test (resident-intruder), social investigation test toward anesthetized conspecific, olfactory preference test, diazepam control\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with specific behavioral phenotype, multiple behavioral paradigms, single lab\",\n      \"pmids\": [\"10869497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Spinal GRPR+ neurons receive inhibitory synaptic inputs from local galanin+ GABAergic neurons and local nNOS-expressing neurons, and also receive strong inhibitory inputs from the rostral ventromedial medulla (long-range). These inhibitory circuits gate GRPR+ neuron-dependent itch signaling.\",\n      \"method\": \"Viral tracing (circuit mapping), electrophysiology (patch-clamp), immunohistochemistry, Grpr-eGFP reporter mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — viral circuit tracing combined with electrophysiology and genetics in a single rigorous study identifying specific inhibitory partners\",\n      \"pmids\": [\"31806757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GRPR interacts with Toll-like receptor 4 to activate STAT1, which binds the promoters of MLKL and CCL2 to induce tubular epithelial cell necroptosis, necroinflammation, and macrophage recruitment in acute kidney injury. STAT1 also induces GRP synthesis, creating a GRP/GRPR/STAT1 positive feedback loop. Histone deacetylase 8 may drive GRPR transcriptional activation.\",\n      \"method\": \"Co-immunoprecipitation (GRPR-TLR4 interaction), STAT1 ChIP (promoter binding), Grpr knockout mice, tubular-specific Grpr conditional knockout (GRPRFlox/Flox/KspCre), STAT1 overexpression rescue, GRPR antagonist RH-1402 treatment, cisplatin and ischemia AKI models\",\n      \"journal\": \"Molecular therapy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP interaction, ChIP, multiple genetic models (global KO, conditional KO, rescue), two disease models, single lab\",\n      \"pmids\": [\"37415332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GRP/GRPR signaling in macrophages/neutrophils promotes alcohol-associated liver injury via two parallel mechanisms: IRF1-mediated Caspase-1 inflammasome activation and NOX2-dependent reactive oxygen species production. Histone H3 lysine 27 acetylation induced by alcohol promotes GRP expression, and GRP then binds GRPR to activate these pathways.\",\n      \"method\": \"Grpr-/- mice, Grprflox/floxLysMCre (myeloid-specific conditional KO) mice, GRPR overexpression, GRPR antagonist RH-1402, chromatin/histone modification analysis, inflammatory cytokine/chemokine measurement, serum biomarkers\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — global KO, myeloid-specific conditional KO, gain-of-function, and pharmacological inhibition with multiple molecular readouts, single lab\",\n      \"pmids\": [\"37409771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GRP/GRPR signaling promotes hyperuricemia-induced renal inflammation and fibrosis by activating NF-κB, which suppresses ABCG2/PDZK1 and increases TGF-β/Smad3 levels. GRPR conditional knockout in renal tubular epithelial cells (GRPRFlox/Flox/KspCre) protected mice from hyperuricemic nephropathy.\",\n      \"method\": \"Renal tubular epithelial cell-specific conditional KO (GRPRFlox/Flox/KspCre), global GRPR KO, RNA-seq, GRPR overexpression in HK2 cells, NF-κB inhibitor rescue, GRPR antagonist RH-1402, ELISA, immunohistochemistry\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-specific conditional KO with rescue experiment, RNA-seq pathway analysis, multiple genetic and pharmacological tools, single lab\",\n      \"pmids\": [\"38084678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GRPR-expressing spinal neurons are identified as vertical cells (glutamatergic interneurons concentrated in lamina I and outer lamina II), accounting for ~15% of excitatory neurons in the superficial dorsal horn. Their axons target GRPR+ neurons themselves, lamina I NK1R projection neurons, lateral spinal nucleus, and lateral lamina V. Most GRPR cells receive monosynaptic input from Trpv1-expressing nociceptive afferents and respond to both noxious and pruritic stimuli. Chemogenetic activation produces both pain- and itch-related behaviors.\",\n      \"method\": \"GRPR-CreERT2 mouse line (conditional genetic targeting), viral tracing, electrophysiology, immunohistochemistry, RNAscope in situ hybridization, chemogenetics (DREADDs), behavioral assays\",\n      \"journal\": \"Pain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic targeting with CreERT2, viral circuit tracing, electrophysiology, chemogenetics, and behavior in a single comprehensive study\",\n      \"pmids\": [\"35543635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Spinal microglia NLRP3/caspase-1/IL-1β axis promotes activation of GRPR+ neurons via IL-1R1, which is expressed on GRPR+ neurons. IL-1β+ microglia localize in close proximity to GRPR+ neurons, and intrathecal IL-1β enhances GRPR+ neuron activation, while IL-1R1 antagonist attenuates chronic itch.\",\n      \"method\": \"Grpr-eGFP and Grpr KO mice, immunohistochemistry, RNAscope ISH, pharmacological blockade (NLRP3, caspase-1, IL-1R1 antagonist), intrathecal IL-1β injection, western blot, behavioral assays, RNA sequencing\",\n      \"journal\": \"Allergy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic reporter/KO mice, direct proximity mapping of microglia-GRPR+ neuron interaction, pharmacological and genetic dissection, multiple models\",\n      \"pmids\": [\"36876522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GRPR (and NPRA) downstream ERK1/2 phosphorylation is the most significantly upregulated signaling cascade in spinal cord during chronic itch. Phosphorylated ERK is detected in GRPR+ interneurons. Genetic blockade of GRPR significantly attenuates spinal ERK phosphorylation. In HEK293T cells transfected with GRPR, GRP activates ERK as the most prominent intracellular signaling molecule.\",\n      \"method\": \"RNA sequencing (spinal cord), western blot (pERK), MAPK/ERK kinase inhibitors, Grpr KO mice, GRPR-transfected HEK293T cells + GRP stimulation, RNAscope, behavioral assays\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — transfected cell signaling assays, genetic KO, RNA-seq, and western blot with multiple itch models, single lab\",\n      \"pmids\": [\"33039402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The GRPR gene on the X chromosome was shown to escape X-inactivation, as established by molecular analysis of a patient with an X;8 translocation whose breakpoint occurred in the first intron of GRPR.\",\n      \"method\": \"Molecular analysis of X;8 translocation patient, YAC and cosmid cloning, X-inactivation analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct molecular mapping, single patient, single lab; escape from X-inactivation directly demonstrated\",\n      \"pmids\": [\"9259269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"177Lu-AMBA (a radiolabeled bombesin analog) binds to GRP-R with high affinity (Kd = 1.02 nmol/L) and is internalized by GRP-R-expressing PC-3 cells (76.8% internalization), with markedly lower efflux (2.9%) compared to other analogs.\",\n      \"method\": \"Radioligand binding assay (Kd, Bmax determination), internalization and efflux assays in PC-3 cells, receptor autoradiography\",\n      \"journal\": \"Journal of nuclear medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding kinetics and internalization assays with quantified parameters, single lab\",\n      \"pmids\": [\"16818949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ERβcx (an estrogen receptor β splice variant) regulates GRPR expression in prostate cancer cells: stable overexpression of ERβcx in PC-3 cells induces GRPR mRNA expression, and GRPR immunoreactivity correlates significantly with ERβcx expression in human prostate cancer specimens.\",\n      \"method\": \"Stable transfection of ERβcx into PC-3 cells, quantitative RT-PCR, immunohistochemistry in 51 human prostate cancer specimens\",\n      \"journal\": \"Neoplasma\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct gain-of-function (stable transfection) with gene expression readout, corroborated by human tissue correlation, single lab\",\n      \"pmids\": [\"22248281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"IL-6 upregulates GRPR expression in hippocampal neurons, and GRP-GRPR activates the PI3K-AKT/mTOR-GSK-3β pathway. GRPR knockdown in HT22 cells abolished IL-6-induced PI3K-AKT/mTOR activation and GSK-3β upregulation.\",\n      \"method\": \"Maternal immune activation mouse model, GRPR knockdown in HT22 cells (with and without GRPR), IL-6 treatment, western blot for PI3K-AKT/mTOR/GSK-3β, NetworkAnalyst bioinformatics\",\n      \"journal\": \"Journal of neuroimmune pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct loss-of-function in cell line with defined pathway readout, corroborated by in vivo expression data, single lab\",\n      \"pmids\": [\"38536552\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GRPR is a G protein-coupled receptor that, upon activation by GRP, signals through PLCβ/IP3R3, PI3Kγ/Akt, and ERK1/2 pathways to mediate itch transmission in spinal cord GRPR+ interneurons (excitatory vertical cells in laminae I–II); it heterodimerizes with MOR1D for opioid-induced itch and with 5-HT1A to potentiate GRP signaling, is controlled by local galanin+/nNOS+ GABAergic interneurons and long-range inhibitory inputs from the rostral ventromedial medulla, and in peripheral immune and epithelial cells activates TLR4/STAT1, NF-κB/TGF-β/Smad3, IRF1/caspase-1 inflammasome, and NOX2/ROS pathways to drive inflammation, necroptosis, and fibrosis in contexts including acute kidney injury, alcohol-associated liver injury, and hyperuricemic nephropathy.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GRPR is a plasma-membrane G protein-coupled receptor for gastrin-releasing peptide (GRP) that serves as a central transmitter of itch in the spinal cord and as a driver of inflammation, necroptosis, and fibrosis in peripheral epithelial and immune tissues [#16, #13]. In the superficial dorsal horn, GRPR marks a population of glutamatergic vertical interneurons concentrated in laminae I\\u2013II that receive monosynaptic input from TRPV1+ nociceptors, contact NK1R+ projection neurons, and respond to both pruritic and noxious stimuli [#16, #2]. Upon GRP binding\\u2014mediated by an inward-facing residue cluster including K101, Q121, R288, and S293 in the ligand pocket [#8]\\u2014activated GRPR depolarizes neurons and signals through PLC\\u03b23/IP3R3, PI3K\\u03b3/Akt, and ERK1/2 cascades to transmit itch [#0, #4, #18]. Receptor function is tuned by heteromerization: GRPR forms a complex with the \\u03bc-opioid receptor isoform MOR1D that cross-activates GRPR to produce opioid-induced itch without affecting analgesia [#0], and with 5-HT1A to potentiate subthreshold GRP responses under descending serotonergic drive [#1]. GRPR+ neuron output is gated by local galanin+ and nNOS+ GABAergic interneurons and by long-range inhibitory inputs from the rostral ventromedial medulla, and is amplified by microglial NLRP3/caspase-1/IL-1\\u03b2 signaling acting through IL-1R1 on GRPR+ neurons in chronic itch [#12, #17]. GRPR also partially overlaps functionally with NMBR in histaminergic itch [#3]. In peripheral disease, GRPR physically interacts with TLR4 to activate STAT1, driving MLKL/CCL2-dependent tubular necroptosis and a GRP/GRPR/STAT1 feedforward loop in acute kidney injury [#13], and engages IRF1/caspase-1 inflammasome and NOX2/ROS pathways in myeloid cells in alcohol-associated liver injury [#14] and NF-\\u03baB/TGF-\\u03b2/Smad3 signaling in hyperuricemic nephropathy [#15]. Beyond these roles, GRPR agonism promotes EMT and tumor growth in prostate cancer cells [#7], and GRPR knockout mice show deficits in fear extinction and altered social investigatory behavior [#10, #11].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Whether GRPR has functions in the brain beyond peptide signaling was addressed by phenotyping knockout mice, revealing a role in social and chemosensory behavior.\",\n      \"evidence\": \"GRPR knockout mice in resident-intruder, social investigation, and olfactory preference tests\",\n      \"pmids\": [\"10869497\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Circuit and molecular mechanism linking GRPR to social behavior not defined\", \"Brain region of action not localized\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"The structural basis of GRP recognition was unknown; systematic mutagenesis mapped the residues conferring high-affinity, selective GRP binding.\",\n      \"evidence\": \"Site-directed mutagenesis of 14 single and combination mutants with radioligand binding and reciprocal gain-of-affinity mutations in BRS-3\",\n      \"pmids\": [\"15670577\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No experimental three-dimensional structure of the GRPR-GRP complex\", \"Residues governing G protein coupling not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Receptor trafficking behavior was clarified by showing plasma-membrane localization and agonist-induced internalization, supporting ligand-targeted imaging strategies.\",\n      \"evidence\": \"Western blot, immunostaining, and bombesin-induced translocation in tumor cells; radioligand binding/internalization with 177Lu-AMBA in PC-3 cells\",\n      \"pmids\": [\"16967266\", \"16818949\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Internalization machinery and recycling fate not characterized\", \"Quantitative kinetics restricted to tumor cell lines\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"How opioids trigger itch was resolved by showing a MOR1D-GRPR heterodimer that cross-activates GRPR/PLC\\u03b23/IP3R3, dissociating itch from analgesia.\",\n      \"evidence\": \"Reciprocal Co-IP, internalization assays, PLC\\u03b23/IP3R3 knockdown, pharmacology, and behavior in mice\",\n      \"pmids\": [\"22000021\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Stoichiometry and structural interface of the heterodimer unknown\", \"Whether the heterodimer operates outside the spinal cord not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"A peripheral, non-neuronal role for GRPR was established by demonstrating it drives GRP-induced neutrophil chemotaxis through a defined kinase cascade.\",\n      \"evidence\": \"In vivo peritoneal recruitment and in vitro chemotaxis with PLC-\\u03b22/PI3K/ERK/p38 inhibitors and GRPR antagonist RC-3095\",\n      \"pmids\": [\"22203955\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"G protein coupling identity left open (shown Gi-independent)\", \"In vivo contribution to specific inflammatory diseases not yet mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"GRPR's CNS role was extended to emotional learning and its transcriptional control was probed, linking it to amygdala-prefrontal circuit balance and estrogen receptor regulation.\",\n      \"evidence\": \"GRPR KO mice in fear extinction with c-Fos mapping; ER\\u03b2cx overexpression in PC-3 cells with RT-PCR and human tissue correlation; X-inactivation mapping in a translocation patient\",\n      \"pmids\": [\"22312434\", \"22248281\", \"9259269\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct transcriptional mechanism of ER\\u03b2cx on GRPR promoter not shown\", \"Causal link between GRPR circuit changes and extinction behavior is correlative (c-Fos)\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"The spinal itch circuit was defined: GRPR+ neurons are excitatory interneurons integrating afferent input, gated by GABA, with NMBR providing partial redundancy in histaminergic itch.\",\n      \"evidence\": \"Patch-clamp of identified GRPR neurons with GABAergic blockade; single and double Nmbr/Grpr knockout mice across pruritogen paradigms\",\n      \"pmids\": [\"31676846\", \"25209280\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Molecular basis of GRP cross-signaling to NMBR not resolved\", \"How noxious versus pruritic inputs are discriminated by these neurons unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"GRPR signal facilitation and effector pathways were defined: 5-HT1A heteromerization potentiates GRP responses, and PI3K\\u03b3/Akt is required for itch transmission, while BNP-NPRA is not upstream.\",\n      \"evidence\": \"Co-IP/Ca2+ imaging/electrophysiology for 5-HT1A; ex vivo Akt phosphorylation, HEK293 transfection, PI3K\\u03b3 inhibition and behavior; genetic/pharmacological BNP epistasis\",\n      \"pmids\": [\"25453842\", \"26658875\", \"24438367\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Interface and stoichiometry of the 5-HT1A-GRPR heteromer not defined\", \"Relative contribution of PI3K\\u03b3/Akt versus PLC and ERK arms not quantified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"An oncogenic function was established by showing GRPR agonism drives EMT, proliferation, and invasion in prostate cancer, reversible by GRPR blockade.\",\n      \"evidence\": \"Stable GRPr transfection of Ace-1 cells with proliferation/migration assays, EMT marker RT-PCR, and in vivo tumor models\",\n      \"pmids\": [\"26939805\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Intracellular signaling pathway coupling GRPR to EMT transcription factors not delineated\", \"Endogenous ligand source in the tumor microenvironment unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"The identity and connectivity of spinal GRPR+ neurons and their dominant signaling output were resolved, defining them as nociceptor-innervated vertical cells signaling through ERK1/2.\",\n      \"evidence\": \"GRPR-CreERT2 mice with viral tracing, electrophysiology, chemogenetics; RNA-seq and pERK western blot in itch models plus GRPR-HEK293T signaling\",\n      \"pmids\": [\"35543635\", \"33039402\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"How a single population encodes both pain and itch is unresolved\", \"Hierarchy among PLC\\u03b2, PI3K\\u03b3, and ERK arms in vivo not established\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Top-down and bottom-up control of GRPR+ neurons in chronic itch was mapped, identifying inhibitory gating circuits and microglial inflammasome-driven facilitation.\",\n      \"evidence\": \"Viral tracing/electrophysiology of galanin+/nNOS+/RVM inputs; Grpr reporter and KO mice with NLRP3/caspase-1/IL-1R1 pharmacology and intrathecal IL-1\\u03b2\",\n      \"pmids\": [\"31806757\", \"36876522\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Conditions selecting disinhibition versus microglial facilitation not defined\", \"Direct synaptic versus diffusible action of microglial IL-1\\u03b2 not fully separated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"GRPR's peripheral pathogenic role was mechanistically expanded across organs, defining receptor-TLR4 coupling and distinct downstream inflammatory effectors in kidney and liver injury.\",\n      \"evidence\": \"GRPR-TLR4 Co-IP and STAT1 ChIP with global/conditional Grpr KO in AKI; myeloid-specific KO with IRF1/caspase-1 and NOX2 readouts in liver injury; tubular-specific KO with NF-\\u03baB/TGF-\\u03b2/Smad3 in hyperuricemic nephropathy\",\n      \"pmids\": [\"37415332\", \"37409771\", \"38084678\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Whether GRPR-TLR4 forms a direct stable complex or transient assembly is unresolved\", \"Source and regulation of local GRP ligand in each disease not fully defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"A cytokine-driven CNS signaling link was identified, with IL-6 upregulating GRPR to engage PI3K-AKT/mTOR-GSK-3\\u03b2 in hippocampal neurons.\",\n      \"evidence\": \"Maternal immune activation model with GRPR knockdown in HT22 cells, IL-6 treatment, and pathway western blots\",\n      \"pmids\": [\"38536552\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanism of IL-6-driven GRPR transcriptional upregulation not defined\", \"Behavioral consequence of hippocampal GRPR signaling not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A unified picture of how GRPR's G protein coupling and effector arm selection (PLC\\u03b2/IP3R3 vs PI3K\\u03b3/Akt vs ERK) is biased across neuronal versus immune/epithelial contexts, and the structural basis of its heteromeric and TLR4 partnerships, remains open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No experimental GRPR structure or activation-state model\", \"Mechanism dictating context-specific effector selection unknown\", \"Direct versus indirect nature of GRPR-TLR4 interaction unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 4, 8, 16]},\n      {\"term_id\": \"GO:0004930\", \"supporting_discovery_ids\": [0, 4, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [9, 20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 4, 18]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [2, 16, 12, 17]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6, 13, 14]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [13, 14, 15, 7]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"MOR1D\", \"HTR1A\", \"TLR4\", \"NMBR\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}